Premier Perspectives The blog for insider insights in clinical development Patient and Stakeholder Engagement “It Motivates Me Every Day”: Our Premier Research Team on Why Rare Disease Research Matters By Angi Robinson February 19, 2021 Featured Posts Medical and Regulatory Affairs The FDA’s New Guidance on Natural History Studies in Rare Diseases: What You Need to Know By Angi Robinson May 1, 2019 Clinical ResearchPhase 1 - Phase 4 Choices, Choices: Which Type of Natural History Study Meets Your Needs? By Angi Robinson August 22, 2017 Recent Posts By expertise area All expertise areas Medical DeviceRare DiseaseOncology & HematologyDiagnosticsDigital TherapeuticsMedTechPediatricsNeuroscienceAnalgesiaDermatologyOtherCOVID-19Cell & Gene TherapyWomen's HealthReal-World & Late PhaseCareers By functional area All functional areas Development StrategyClinical Research: Phase 1 - Phase 4ConsultingData Management & BiostatisticsFunctional Service Provider (FSP)Global ComplianceMedical and Regulatory AffairsPatient and Stakeholder EngagementProject ManagementQualityReal-World Science and Late PhaseSafety/PharmacovigilanceStudy DesignStudy Start-UpOtherCOVID-19Product Development Clinical ResearchPhase 1 - Phase 4 The Top 5 Concerns for Pediatric Study Participants By Angi Robinson July 5, 2017 Clinical ResearchPhase 1 - Phase 4 Strategies for Finding ‘Hidden’ Patient Populations By Angi Robinson May 2, 2017 Clinical ResearchPhase 1 - Phase 4 Natural History Studies: A Growing Force in Treating Rare Diseases By Angi Robinson April 19, 2017 Clinical ResearchPhase 1 - Phase 4 Natural History vs. Registry Studies in Rare Disease By Angi Robinson April 12, 2017 Clinical ResearchPhase 1 - Phase 4 Want to Study Rare Disease? Get Ready for These Roadblocks By Angi Robinson January 12, 2017 Clinical ResearchPhase 1 - Phase 4 Rare Disease Research: 3 Biggest Hang-Ups to Patient Recruitment By Angi Robinson January 5, 2017 1 2 Next × ALSO OF INTERESTRare Disease and Pediatrics Expert to Address...Planning Rare Disease Studies: Our Top Expert...Premier Voices #2: Registry Studies & Natural...
